DNDi Drug Discovery Explained:

IPK's High-throughput Screening Research
 

Institut Pasteur Korea's High-throughput screening research and development was featured in DNDi’s (Drugs for Neglected Diseases initiative) ongoing series on drug discovery explained content. The content highlighted IPK's cutting-edge screening research processes and key features, as well as its collaborative research efforts with DNDi and international research institutes.

IPK’s outstanding screening technology was recognized for its significant contributions to discovering new drug candidates, earning the 'Project of the Year' award in 2016, 2017, and 2023.

Explore the research and development sites introduced by IPK researchers through vivid photos and detailed text!

▶ (URL) Drug Discovery Explained - Episode 2 (IPK)